Fund buys $11 million in shares, raising stake to 3.37%
Deep Track Capital has increased its position in Structure Therapeutics by 168,066 shares, with an estimated transaction value of $11.50 million.
The quarter-end value of the stake decreased by $79.69 million, a change that includes both share purchases and stock price movement.
As of March 31, 2026, the fund’s top holdings included NASDAQ:GH, NASDAQ:IMVT, and NASDAQ:TARS, with values of $308.35 million, $286.33 million, and $252.54 million, respectively.
Structure Therapeutics shares were priced at $39.19, up 60% over the past year, outperforming the S&P 500